Loss of FHIT protein expression correlates with disease progression and poor differentiation in gastric cancer
- 1 February 2003
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 129 (2) , 84-88
Abstract
Purpose The fragile histidine triad (FHIT) gene has recently been proposed as being a tumor suppressor gene. FHIT gene deletions or aberrant transcripts have been identified in a variety of human malignancies, including gastric carcinomas, suggesting that FHIT may play a key role in tumor development. However, the clinical impact of FHIT mutations in gastric carcinogenesis is still debated. Our purpose was to investigate whether FHIT expression in human primary gastric carcinoma is associated with the histological type, grade or stage of the tumor. Methods We analyzed a well-characterized set of 137 primary gastric cancers. FHIT protein expression was evaluated in gastric mucosal samples, both from the tumor and tumor-free areas by immunohistochemistry. Furthermore, in a subgroup of 30 patients, FHIT mRNA expression was assessed by nested RT-PCR. Results Absent or reduced expression of FHIT protein correlated significantly with diffuse type (PPP<0.0001) of gastric cancer. In contrast, FHIT protein was strongly expressed and uniformly distributed in tumor-free areas. The FHIT mRNA expression was absent or altered in diffuse and poorly differentiated carcinomas. Conclusion These results show that the expression of FHIT in gastric carcinoma is related to the type, grade, and stage of the tumor. We suggest that FHIT expression may be considered a potential prognostic factor in gastric cancer.Keywords
This publication has 34 references indexed in Scilit:
- Fragile Histidine Triad Gene Abnormalities in the Pathogenesis of Gallbladder CarcinomaThe American Journal of Pathology, 2002
- Characterization of aberrant FHIT transcripts in gastric adenocarcinomasExperimental & Molecular Medicine, 2001
- Altered Expression of the Fragile Histidine Triad Gene in Primary Gastric AdenocarcinomasBiochemical and Biophysical Research Communications, 2001
- FHIT andp53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutationsThe Journal of Pathology, 1998
- Cellular and molecular pathology of gastric carcinoma and precursor lesions: A critical reviewGastric Cancer, 1998
- Gastric CarcinomaNew England Journal of Medicine, 1995
- Meningiomas and Gliomas in JuxtapositionAmerican Journal of Surgical Pathology, 1995
- Adenocarcinoma of the stomach: are we making progress?The Lancet, 1993
- Molecular mechanism of stomach carcinogenesisJournal of Cancer Research and Clinical Oncology, 1993
- Molecular biology and gastric carcinoma.Gut, 1993